CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 38 filers reported holding CYTOSORBENTS CORP in Q1 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $168,000 | -74.1% | 14,737 | -85.2% | 0.00% | -66.7% |
| Q4 2017 | $648,000 | +19.1% | 99,744 | +13.7% | 0.00% | +50.0% |
| Q3 2017 | $544,000 | +497.8% | 87,722 | +313.2% | 0.00% | +100.0% |
| Q2 2017 | $91,000 | +12.3% | 21,231 | +18.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | +28.6% | 18,000 | +79.8% | 0.00% | – |
| Q3 2015 | $63,000 | – | 10,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |